SCHEMBL502534

SCHEMBL502534

COc1cc(C(N)=O)cc(OC)c1O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 3/20 0.67
CA12 O43570 2/20 0.67
CA1 P00915 2/20 0.67
CA2 P00918 2/20 0.67
CA4 P22748 2/20 0.67
CA6 P23280 2/20 0.67
CA7 P43166 2/20 0.67
CA9 Q16790 2/20 0.67
CA14 Q9ULX7 2/20 0.67
CA3 P07451 1/20 0.67
CA5A P35218 1/20 0.67
CA5B Q9Y2D0 1/20 0.67
LMNA P02545 1/20 0.67
TSHR P16473 3/20 0.59
APOBEC3A P31941 1/20 0.59
HTT P42858 1/20 0.59
APOBEC3G Q9HC16 1/20 0.59
PTGS2 P35354 2/20 0.57
KMT2A Q03164 2/20 0.53
ALDH1A1 P00352 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16358844 0.92 PTGS2 (0.69) PKMCA12CA1CA2CA4
SCHEMBL15242142 0.88 CA1 (0.53) PKMCA12CA1CA2CA4
SCHEMBL18476765 0.87 BPTF (0.60) PKMCA12CA1CA2CA4
SCHEMBL13900898 0.84 TSHR (0.49) PKMCA12CA1CA2CA4
SCHEMBL11850840 0.83 TSHR (0.59) PKMCA12CA1CA2CA4
3,4,5-Trimethoxybenzamide SCHEMBL1326890 0.83 TSHR (0.76) TSHRAPOBEC3AHTTAPOBEC3GKMT2A
SCHEMBL1004561 0.83 TSHR (0.59) PKMCA12CA1CA2CA4
SCHEMBL15288999 0.82 PKM (0.72) PKMCA12CA1CA2CA4
SCHEMBL27905025 0.82 PKM (0.72) PKMCA12CA1CA2CA4
3,4,5-Trimethoxybenzamide SCHEMBL4381076 0.81 TSHR (0.73) TSHRAPOBEC3AHTTAPOBEC3GALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2350250-B2 DELIVERY SYSTEM FOR CO-FORMULATED ENZYME AND SUBSTRATE DANISCO US INC (US) 2022-11-30 EP claimed
EP-0900781-B1 Phenolic acid amides of hydroxy substituted benzylamines HAARMANN & REIMER GMBH (DE) 2002-03-20 EP claimed
US-12305215-B2 Microbiomes and methods for producing medium-chain fatty acids from organic substrates WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2025-05-20 US disclosed
CN-119968127-A Animal food compositions with improved palatability and customizable properties and methods of making the same 玛氏公司 2025-05-09 CN disclosed
US-20250092009-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2025-03-20 US disclosed
CN-112424181-B Substituted condensed thiophenes as STING modulators 希泰克斯特私人有限公司 2024-02-27 CN disclosed
EP-3793988-B1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-11-15 EP disclosed
EP-3793988-B1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-11-15 EP disclosed
US-20230227423-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-07-20 US disclosed
US-20230227423-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-07-20 US disclosed
US-20230227423-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-07-20 US disclosed
WO-2008076322-A2 NOVEL LACCASES, COMPOSITIONS AND METHODS OF USE DANISCO US, INC., GENENCOR DIVISION (US) 2008-06-26 WO disclosed
WO-2008076323-A2 LACCASE MEDIATORS AND METHODS OF USE DANISCO US, INC., GENENCOR DIVISION (US) 2008-06-26 WO disclosed
EP-0322926-B2 Assays utilizing improved chemiluminescent esters, thioesters and amides NICHOLS INST DIAGNOSTICS (US) 2004-03-31 EP disclosed
EP-0322926-B1 Assays utilizing improved chemiluminescent esters, thioesters and amides NICHOLS INST DIAGNOSTICS (US) 1999-08-11 EP disclosed
EP-0916658-A1 Assays utilizing improved chemiluminescent esters, thioesters and amides Nichols Institute Diagnostics (US) 1999-05-19 EP disclosed
US-5338847-A Hydrolytically stable chemiluminescent labels and their conjugates, and assays therefrom by adduct formation LONDON DIAGNOSTICS, INC. (US) 1994-08-16 US disclosed
US-5284951-A Aryl ester, thioester or amide of carboxylic acid substituted heterocyclic ring; quaternary compounds LONDON DIAGNOSTICS, INC. (US) 1994-02-08 US disclosed
WO-1989006231-A1 ASSAYS UTILIZING IMPROVED CHEMILUMINESCENT ESTERS, THIOESTERS AND AMIDES LONDON DIAGNOSTICS, INC. (US) 1989-07-13 WO disclosed
EP-0322926-A2 Assays utilizing improved chemiluminescent esters, thioesters and amides LONDON DIAGNOSTICS, INC. (US) 1989-07-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227423-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING STING1, CGAS, IRF3 PKM 3886/4885CA12 743/4885CA1 1069/4885
US-20250092009-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING STING1, CGAS, IRF3 PKM 3886/4885CA12 743/4885CA1 1069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.